Matrix pellets based on the combination of waxes, starches and maltodextrins

International Journal of Pharmaceutics

Volumn 133, Issue 1-2, 1996, Pages 155-160

  Zhou, F ^a   Vervaet, C ^a   Remon, J P ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Maltodextrin; Matrix pellets; Melt pelletization; Microcrystalline wax; Starch

Indexed keywords

BENZOIC ACID; CHLOROQUINE; IBUPROFEN; MALTODEXTRIN; SALICYLATE SODIUM; STARCH; WAX;

ARTICLE; DIFFUSION; DISSOLUTION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; PHYSICAL PHENOMENA; PRIORITY JOURNAL;

EID: 0029941965     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04431-0     Document Type: Article

References (15)

1. Adeyeye, C.M. and Price, J.C., Development and evaluation of sustained-release ibuprofen-wax microspheres. II In vitro dissolution studies. Pharm. Res., 11 (1994) 575-579.
2. Belgian Patent Application no. 09500248.
3. Betageri, G.V., Kurumaddali, K.R. and Ravis, S.R., Preparation and in vitro evaluation of mefenamic acid sustained release beads. Drug Dev. Ind. Pharm., 21 (1995) 265-275.
4. Bianchini, R., Bruni, G., Gazzaniga A. and Vecchio, C., Influence of extrusion-spheronization on the physical properties of d-indobufen pellets containing pH adjusters. Drug Dev. Ind. Pharm., 18 (1992) 1485-1503.
5. Briquet, F., Brossard, C., Ser, J. and Duchêne, D.,Optimisation de la formulation par extrusion-sphéronisation de microgranules matriciels à libération prolongée. STP Pharm., 2 (1986) 986-994.
6. Ghali, E.S., Klinger, G.H. and Schwartz J.B., Modified drug release from beads prepared with combinations of two grades of microcrystalline cellulose. Drug Dev. Ind. Pharm., 15 (1989a) 1455-1473.
7. Ghali, E.S., Klinger, G.H. and Schwartz J.B., Thermal treatment of beads with wax for controlled release. Drug Dev. Ind. Pharm., 15 (1989b) 1311-1328.
8. Goskonda, S.R., Hileman, G.A. and Upadrashta, S.M., Development of matrix controlled release beads by extrusion spheronization technology using a statistical screening design. Drug. Dev. Ind. Pharm., 20 (1994a) 279-292.
9. Goskonda, S.R. and Upadrashta, S.M., Avicel RC-591 / chitosan beads by extrusion-spheronisation technology. Drug Dev. Ind. Pharm., 19 (1993) 915-927.
10. Goskonda, S.R., Hileman, G.A. and Upadrashta, S.M., Con3 trolled release pellets by extrusion-spheronization. Int. J. Pharm., 111 (1994b) 89-97.
11. Kurumaddali, K.R., Ravis, W.R. and Betageri, G.V., Preparation and evaluation of sustained release ibuprofen beads. Drug Dev. Ind. Pharm., 20 (1994) 2659-2669.
12. McTaggart, C.M., Ganley, J.A., Sickmueller, A. and Walker, S.E., Int. J. Pharm., 19 (1984) 139-148.
13. O'Connor, R.E. and Schwartz, J.B., Spheronization II: Drug release from drug - diluent mixtures. Drug Dev. Ind. Pharm., 11 (1985) 1837-1857.
14. Tapia, C., Buckton, G. and Newton, J.M., Factors influencing the mechanism of release from sustained release matrix pellets, produced by extrusion/spheronisation. Int. J. Pharm., 92 (1993) 211-218.
15. Wong, L.P., Gilligan, C.A. and Li Wan Po, A., Preparation and characterisation of sustained-release ibuprofen-cetostearyl alcohol spheres. Int. J. Pharm., 83 (1992) 95-114.